While it’s a good idea to go through your portfolio at least once a quarter and evaluate how your stocks are doing, special circumstances dictate that you do it more scrupulously, and our present pandemic certainly counts.
The markets are caught in limbo, awaiting another stimulus package after a massive run from late March through September.
The biggest winners have been tech stocks, especially biotechs and pharmaceutical companies. Much of that hype initially centered on the race for a...
READ FULL ARTICLE »